Compare Stocks: ULYX, VSQTF, POAI, and CLPS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPS CLPS Incorporation	$1.02 -4.6%	$0.92	$0.80 ▼ $1.88	$31.93M	0.75	22,977 shs	1,993 shs
POAI Predictive Oncology	$10.56 -3.3%	$8.77	$0.71 ▼ $16.54	$35.84M	1.35	473,545 shs	182,808 shs
ULYX Urgent.ly	$5.50	$5.50	$1.74 ▼ $17.99	$12.07M	-5.01	17,545 shs	N/A
VSQTF Victory Square Technologies	$0.41 +1.0%	$0.47	$0.30 ▼ $0.72	$42.63M	1.82	40,712 shs	5,668 shs

10 Best Stocks to Own - Fall 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPS CLPS Incorporation	-4.58%	-3.68%	+16.69%	+5.26%	+0.10%
POAI Predictive Oncology	-3.30%	+6.88%	+31.84%	+48.52%	-25.89%
ULYX Urgent.ly	0.00%	0.00%	0.00%	0.00%	+39.82%
VSQTF Victory Square Technologies	+0.95%	-6.18%	-10.69%	-18.24%	-19.78%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPS CLPS Incorporation	$1.02 -4.6%	$0.92	$0.80 ▼ $1.88	$31.93M	0.75	22,977 shs	1,993 shs
POAI Predictive Oncology	$10.56 -3.3%	$8.77	$0.71 ▼ $16.54	$35.84M	1.35	473,545 shs	182,808 shs
ULYX Urgent.ly	$5.50	$5.50	$1.74 ▼ $17.99	$12.07M	-5.01	17,545 shs	N/A
VSQTF Victory Square Technologies	$0.41 +1.0%	$0.47	$0.30 ▼ $0.72	$42.63M	1.82	40,712 shs	5,668 shs

10 Best Stocks to Own - Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPS CLPS Incorporation	-4.58%	-3.68%	+16.69%	+5.26%	+0.10%
POAI Predictive Oncology	-3.30%	+6.88%	+31.84%	+48.52%	-25.89%
ULYX Urgent.ly	0.00%	0.00%	0.00%	0.00%	+39.82%
VSQTF Victory Square Technologies	+0.95%	-6.18%	-10.69%	-18.24%	-19.78%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLPS CLPS Incorporation	1.00	Sell	N/A	N/A
POAI Predictive Oncology	1.00	Sell	N/A	N/A
ULYX Urgent.ly	2.00	Hold	$6.75	22.84% Upside
VSQTF Victory Square Technologies	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest ULYX, VSQTF, POAI, and CLPS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
7/21/2026	CLPS CLPS Incorporation	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)

(Data available from 9/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLPS CLPS Incorporation	$164.23M	0.19	N/A	N/A	$2.07 per share	0.49
POAI Predictive Oncology	$1.66M	21.53	N/A	N/A	($0.46) per share	-22.96
ULYX Urgent.ly	$129.19M	0.09	N/A	N/A	($21.20) per share	-0.26
VSQTF Victory Square Technologies	$25.32M	1.70	$0.02 per share	23.45	$0.19 per share	2.17

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLPS CLPS Incorporation	-$7.05M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
POAI Predictive Oncology	-$12.66M	-$13.50	N/A	N/A	N/A	-5,065.23%	-732.73%	-235.55%	N/A
ULYX Urgent.ly	-$20.43M	-$13.82	N/A	N/A	N/A	-15.81%	N/A	-47.23%	N/A
VSQTF Victory Square Technologies	$1.46M	$0.05	8.26	N/A	N/A	6.20%	15.90%	10.68%	12/1/2026 (Estimated)

Latest ULYX, VSQTF, POAI, and CLPS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/31/2026	Q2 2026	VSQTF Victory Square Technologies	N/A	$0.01	N/A	$0.01	N/A	$20.25 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLPS CLPS Incorporation	N/A	N/A	N/A	N/A	N/A
POAI Predictive Oncology	N/A	N/A	N/A	N/A	N/A
ULYX Urgent.ly	N/A	N/A	N/A	N/A	N/A
VSQTF Victory Square Technologies	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLPS CLPS Incorporation	N/A	1.69	N/A
POAI Predictive Oncology	N/A	0.01	0.01
ULYX Urgent.ly	N/A	0.34	0.34
VSQTF Victory Square Technologies	0.19	5.04	5.04

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLPS CLPS Incorporation	0.24%
POAI Predictive Oncology	9.04%
ULYX Urgent.ly	28.30%
VSQTF Victory Square Technologies	N/A

Insider Ownership

Company	Insider Ownership
CLPS CLPS Incorporation	58.72%
POAI Predictive Oncology	1.21%
ULYX Urgent.ly	3.10%
VSQTF Victory Square Technologies	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLPS CLPS Incorporation	3,534	29.84 million	12.32 million	Optionable
POAI Predictive Oncology	30	3.39 million	3.35 million	Not Optionable
ULYX Urgent.ly	753	2.20 million	2.13 million	No Data
VSQTF Victory Square Technologies	N/A	104.26 million	N/A	Not Optionable

ULYX, VSQTF, POAI, and CLPS Headlines

Recent News About These Companies

Victory Square Technologies Inc. publie ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2026

September 2, 2026 | zonebourse.comZ

Victory Square Technologies Reports First-Half 2026 Revenue of $53.0 Million and Net Income of $6.5 Million

September 1, 2026 | prnewswire.com

Hydreight Reports Record Q2 2026 Revenue of $28.0 Million, Net Income of $2.5 Million and Adjusted EBITDA of $3.2 Million

August 31, 2026 | prnewswire.com

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

August 27, 2026 | prnewswire.com

Hydreight to Participate in Canaccord Genuity's 46th Annual Growth Conference in Boston

August 6, 2026 | prnewswire.com

Victory Square Technologies Inc: Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk ...

July 30, 2026 | finanznachrichten.de

Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances

July 29, 2026 | newswire.ca

Hydreight Provides Business Update on its Peptide Healthcare Platform Following Recent FDA Advisory Committee Recommendations

July 29, 2026 | prnewswire.com

Victory Square Technologies Inc: Victory Square Reports Q1 2026 Financial Results and Provides Portfolio Update

June 3, 2026 | finanznachrichten.de

Victory Square Reports Q1 2026 Financial Results and Provides Portfolio Update

June 1, 2026 | prnewswire.com

Hydreight Delivers Record First Quarter 2026 Revenue of $24.9 Million with 449% Revenue Growth, $3.3 Million in Adjusted EBITDA² and $32.0 Million in Working Capital

June 1, 2026 | prnewswire.com

Hydreight Technologies Announces Timing of Q1 2026 Financial Results and Investor Webcast

May 26, 2026 | prnewswire.com

Victory Square Technologies Reports Fiscal 2025 Results Highlighting Platform Scaling, Healthcare Infrastructure Growth and Portfolio Momentum

April 30, 2026 | prnewswire.com

Hydreight Reports Record Fiscal 2025 Results as VSDHOne Drives Rapid Growth and Platform Scale

April 30, 2026 | prnewswire.com

Victory Square Technologies Declares a Special Common Share Dividend of Its Interest in Yocale.ai Inc.

April 20, 2026 | newswire.ca

Hydreight Announces Normal Course Issuer Bid

March 9, 2026 | prnewswire.com

Victory Square Provides Corporate Update on Healthcare Infrastructure Strategy and Portfolio Developments

February 18, 2026 | newsfilecorp.comN

Victory Square Technologies Reports Strong Q3 2025 Results and Strategic Growth

December 1, 2025 | tipranks.com

Victory Square Technologies Reports Q3 2025 Financial Results & Provides Corporate Update

December 1, 2025 | newsfilecorp.comN

Victory Square Technologies to Launch Share Buyback (NCIB) as Balance Sheet Clears; Announces NAV-Focused Investor Webinar

September 22, 2025 | newsfilecorp.comN

New MarketBeat Followers Over Time

Media Sentiment Over Time

ULYX, VSQTF, POAI, and CLPS Company Descriptions

CLPS Incorporation NASDAQ:CLPS

$1.02 -0.05 (-4.58%)

Closing price 09/11/2026 03:57 PM Eastern

Extended Trading

$1.02 0.00 (-0.10%)

As of 09/11/2026 06:49 PM Eastern

CLPS Incorporation provides information technology (IT), consulting, and solutions to institutions operating in banking, insurance, and financial sectors in the People's Republic of China and internationally. It offers IT consulting services in credit card business areas, such as credit card application, account setup, authorization and activation, settlement, collection, promotion, point system, anti-fraud, statement, reporting, and risk management. The company also provides banking services, including business analysis, system design, development, testing, system maintenance, and operation support; and services in loans, deposit, general ledger, wealth management, debit card, anti-money-laundering, statement and reporting, and risk management, as well as architecture consulting services for banking systems, and online and mobile banking. In addition, it offers solutions in the field of wealth management; e-commerce solutions in online platforms, cross-border e-commerce, logistics, and back-end technology, such as big data analysis and intelligent decision-making; and driving, automatic control, and other AI-driven technology solutions for the automotive industry. Further, the company provides IT services to its clients in the banking, wealth management, e-commerce, and automotive industries; and software project development, maintenance, and testing services. Additionally, it offers CLPS Virtual Banking platform, a training platform for IT talents; recruitment and headhunting; and fee-for-service training services, as well as sells product and third-party software. The company was founded in 2005 and is headquartered in Kwun Tong, Hong Kong.

Predictive Oncology NASDAQ:POAI

$10.56 -0.36 (-3.30%)

As of 09/10/2026

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.

Urgent.ly OTCMKTS:ULYX

$5.50 0.00 (0.00%)

As of 09/10/2026

URGENT.LY INC

Victory Square Technologies OTCMKTS:VSQTF

$0.41 +0.00 (+0.95%)

As of 09/11/2026 02:31 PM Eastern

Victory Square Technologies Inc. is a private equity and venture capital firm specializing in incubation, acquisition and invests in startups, Early stage and provides the senior leadership and resources needed to growth. Through its portfolio companies it focuses on technologies in blockchain, digital health, web3, creator economy, metaverse, machine learning, climate tech, youth, mental health, healthcare, special needs, technology, First Nation, artificial intelligence, and virtual reality/augmented reality, health, mobile gaming, film, esports, cannabis, and education. The company formerly known as Fantasy 6 Sports Inc. and changed its name to Victory Square Technologies Inc. in June 2017. It prefers to take minority investment in the companies. Victory Square Technologies Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada with an additional office in Lewes, Delaware.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ULYX, VSQTF, POAI, and CLPS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ULYX, VSQTF, POAI, and CLPS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ULYX, VSQTF, POAI, and CLPS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ULYX, VSQTF, POAI, and CLPS Company Descriptions

CLPS Incorporation NASDAQ:CLPS

Predictive Oncology NASDAQ:POAI

Urgent.ly OTCMKTS:ULYX

Victory Square Technologies OTCMKTS:VSQTF

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ULYX, VSQTF, POAI, and CLPS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ULYX, VSQTF, POAI, and CLPS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ULYX, VSQTF, POAI, and CLPS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ULYX, VSQTF, POAI, and CLPS Company Descriptions

CLPS Incorporation NASDAQ:CLPS

Predictive Oncology NASDAQ:POAI

Urgent.ly OTCMKTS:ULYX

Victory Square Technologies OTCMKTS:VSQTF

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools